Jiaying Pharmaceutical (002198.SZ) released its report for the first quarter of 2024, achieving 944 operating income during the reporting period...
According to the Zhitong Finance App, Jiaying Pharmaceutical (002198.SZ) released its report for the first quarter of 2024. During the reporting period, it achieved revenue of 94.415 million yuan, a year-on-year decrease of 26.52%. Net profit attributable to shareholders of listed companies was 5.1822 million yuan, a year-on-year decrease of 57.47%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was $3.7944 million, a year-on-year decrease of 65.56%.
